Wang Xiaolin bought RVMD
March 1, 2026 · Form 4 insider transaction
Wang Xiaolin bought 34,000 shares of Revolution Medicines, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
34,000
Price
$0.00
Total value
N/A
InsiderWang Xiaolin
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after34,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.